Literature DB >> 28165727

Transition State-Based Sialyltransferase Inhibitors: Mimicking Oxocarbenium Ion by Simple Amide.

Jian Guo1, Wenming Li1, Weiwei Xue2, Xin-Shan Ye1.   

Abstract

In the new transition-state based sialyltransferase inhibitors, an amide group was placed at the corresponding C-2 position of CMP-sialic acid to mimic the geometry and charge distribution in the transition state, and simple aromatic or aliphatic rings were used instead of the sialic acid moiety. All synthetic compounds exhibited excellent α(2-6)-sialyltransferase inhibition, resulting in up to a 2600-fold higher affinity for the enzyme than CMP-Neu5Ac, suggesting that amide is a key element for simulating transition-state features.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28165727     DOI: 10.1021/acs.jmedchem.6b01644

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  5 in total

1.  Synthesis and biological evaluation of selective phosphonate-bearing 1,2,3-triazole-linked sialyltransferase inhibitors.

Authors:  Christopher Dobie; Andrew P Montgomery; Rémi Szabo; Haibo Yu; Danielle Skropeta
Journal:  RSC Med Chem       Date:  2021-06-29

2.  Transition state-based ST6Gal I inhibitors: Mimicking the phosphodiester linkage with a triazole or carbamate through an enthalpy-entropy compensation.

Authors:  Andrew P Montgomery; Danielle Skropeta; Haibo Yu
Journal:  Sci Rep       Date:  2017-10-31       Impact factor: 4.379

Review 3.  Selectins-The Two Dr. Jekyll and Mr. Hyde Faces of Adhesion Molecules-A Review.

Authors:  Igor Tvaroška; Chandrabose Selvaraj; Jaroslav Koča
Journal:  Molecules       Date:  2020-06-19       Impact factor: 4.411

Review 4.  Aberrant Sialylation in Cancer: Biomarker and Potential Target for Therapeutic Intervention?

Authors:  Silvia Pietrobono; Barbara Stecca
Journal:  Cancers (Basel)       Date:  2021-04-22       Impact factor: 6.639

Review 5.  Insights into the role of sialylation in cancer progression and metastasis.

Authors:  Christopher Dobie; Danielle Skropeta
Journal:  Br J Cancer       Date:  2020-11-04       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.